← Dashboard
Stock
MDT
Medtronic plcHealth CareHealth Care Equipment6 of 27 marquee funds currently hold2 CUSIPs mapped
Current holders
6
27 funds tracked
Ever held
13
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 13, 2013Nov 14, 2018Nov 10, 2022Nov 14, 2025
Now
6
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2013 | 52Q | $0.00 | — | — |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Point72 Asset Management | Q4 2024 | Q4 2025 | — | +0% |
| Renaissance Technologies 2× in & out | Q3 2025 | Q4 2025 | — | +0% |
| Glenview Capital 3× in & out | Q4 2023 | Q1 2024 | — | +0% |
| Maverick Capital 2× in & out | Q1 2021 | Q1 2022 | — | +0% |
| Coatue Management | Q1 2020 | Q2 2020 | — | +0% |
| Duquesne Family Office | Q4 2018 | Q2 2019 | — | +0% |
| Viking Global Investors | Q4 2014 | Q1 2015 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Medtronic plc. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
12
Filings · last 90d
25
Total on file
597
Recent SEC buffer
Most recent
Jun 9, 2026
30d / 90d windows measured from Jun 9, 2026 — the most recent Form 4 on file — not from today.
- Form 40001708062-26-000008Jun 9, 2026
- Form 40001708062-26-000006Jun 8, 2026
- Form 40001560409-26-000006Jun 8, 2026
- Form 40001984186-26-000004Jun 8, 2026
- Form 40002028475-26-000006Jun 8, 2026
- Form 40002061393-26-000010Jun 8, 2026
- Form 40002028475-26-000004May 28, 2026
- Form 40001473812-26-000002May 28, 2026
- Form 40001560409-26-000004May 28, 2026
- Form 40001984186-26-000002May 28, 2026
- Form 40001708062-26-000004May 28, 2026
- Form 40002061393-26-000008May 28, 2026
- Form 40002028475-26-000002May 4, 2026
- Form 40002061393-26-000006Apr 29, 2026
- Form 40001298823-26-000002Apr 29, 2026
Showing 15 of 597 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · Medtronic plcAnnual figures sourced directly from Medtronic plc's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$33.54B
FY2025+4% YoY
Net income
$4.66B
FY2025+27% YoY
EPS (diluted)
$3.61
FY2025+31% YoY
Free cash flow(?)
$5.19B
FY2025-0% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Medtronic plc — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 3, 2026
- 8-KMaterial eventMay 18, 2026
- 8-KMaterial eventApr 27, 2026
- 8-KMaterial eventMar 24, 2026
- 10-QQuarterly reportFeb 24, 2026
- 8-KMaterial eventFeb 17, 2026
- 10-QQuarterly reportNov 25, 2025
- 8-KMaterial eventNov 18, 2025
- 8-KMaterial eventNov 3, 2025
- 8-KMaterial eventOct 21, 2025
- 8-KMaterial eventSep 29, 2025
- 8-KMaterial eventSep 16, 2025
- 10-QQuarterly reportAug 26, 2025
- DEF 14AProxy statementAug 25, 2025
- 8-KMaterial eventAug 19, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2025 | Q4 2025 | $0.00 | — | +0% |
| Point72 Asset Management | Q4 2024 | Q4 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | open | $0.00 | — | +0% |
| Two Sigma Investments | Q3 2024 | open | $0.00 | — | +0% |
| D.E. Shaw | Q3 2024 | open | $0.00 | — | +0% |
| AQR Capital Management | Q3 2024 | open | $0.00 | — | +0% |
| Millennium Management | Q3 2024 | open | $0.00 | — | +0% |
| Renaissance Technologies | Q3 2024 | Q2 2025 | $0.00 | — | +0% |
| Bridgewater Associates | Q2 2024 | open | $0.00 | — | +0% |
| Glenview Capital | Q4 2023 | Q1 2024 | $0.00 | — | +0% |
| Bridgewater Associates | Q2 2022 | Q4 2022 | $0.00 | — | +0% |
| Maverick Capital | Q1 2021 | Q1 2022 | $0.00 | — | +0% |
| Glenview Capital | Q4 2020 | Q4 2021 | $0.00 | — | +0% |
| Glenview Capital | Q2 2020 | Q3 2020 | $0.00 | — | +0% |
| Coatue Management | Q1 2020 | Q2 2020 | $0.00 | — | +0% |
| Maverick Capital | Q1 2019 | Q2 2019 | $0.00 | — | +0% |
| Duquesne Family Office | Q4 2018 | Q2 2019 | $0.00 | — | +0% |
| Bridgewater Associates | Q1 2018 | Q2 2018 | $0.00 | — | +0% |
| Bridgewater Associates | Q4 2016 | Q2 2017 | $0.00 | — | +0% |
| Bridgewater Associates | Q2 2015 | Q2 2016 | $0.00 | — | +0% |
| Viking Global Investors | Q4 2014 | Q1 2015 | $0.00 | — | +0% |
| Bridgewater Associates | Q4 2014 | Q2 2015 | $0.00 | — | +0% |
| Bridgewater Associates | Q3 2013 | Q3 2014 | $0.00 | — | +0% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.